These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16723360)

  • 41. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.
    Recchia FM; Ruby AJ; Carvalho Recchia CA
    Am J Ophthalmol; 2005 Mar; 139(3):447-54. PubMed ID: 15767052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term results of pars plana vitrectomy in the management of complicated uveitis.
    Heiligenhaus A; Bornfeld N; Foerster MH; Wessing A
    Br J Ophthalmol; 1994 Jul; 78(7):549-54. PubMed ID: 7918267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
    Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
    Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
    Yanyali A; Nohutcu AF; Horozoglu F; Celik E
    Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema.
    Sevim MS; Sanisoglu H; Turkyilmaz K
    Curr Eye Res; 2012 Dec; 37(12):1165-70. PubMed ID: 22928501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema.
    Harbour JW; Smiddy WE; Rubsamen PE; Murray TG; Davis JL; Flynn HW
    Am J Ophthalmol; 1995 Sep; 120(3):302-7. PubMed ID: 7661201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
    Sørensen TL; Haamann P; Villumsen J; Larsen M
    Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
    Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
    Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term results of pars plana vitrectomy as an anti-inflammatory therapy of pediatric intermediate uveitis resistant to standard medical treatment.
    Darsová D; Pochop P; Štěpánková J; Dotřelová D
    Eur J Ophthalmol; 2018 Jan; 28(1):98-102. PubMed ID: 28862736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.
    Yamamoto T; Hitani K; Sato Y; Yamashita H; Takeuchi S
    Ophthalmologica; 2005; 219(4):206-13. PubMed ID: 16088239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies.
    Soheilian M; Karimi S; Ramezani A; Peyman GA
    Retina; 2010 Mar; 30(3):509-15. PubMed ID: 19952986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes.
    Ikeda T; Sato K; Katano T; Hayashi Y
    Br J Ophthalmol; 1999 Jan; 83(1):12-4. PubMed ID: 10209427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pars plana vitrectomy for aphakic cystoid macular edema.
    Patel A; de Bustros S; Michels RG
    Retina; 1985; 5(1):11-5. PubMed ID: 4001583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cystoid puncture for chronic cystoid macular oedema.
    Singh RP; Margolis R; Kaiser PK
    Br J Ophthalmol; 2007 Aug; 91(8):1062-4. PubMed ID: 17229807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cystoid macular edema after pars plana vitrectomy for retained lens fragments.
    Cohen SM; Davis A; Cukrowski C
    J Cataract Refract Surg; 2006 Sep; 32(9):1521-6. PubMed ID: 16931266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment].
    Paire V; Lebreton O; Weber M
    J Fr Ophtalmol; 2010 Mar; 33(3):152-62. PubMed ID: 20181409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pars plana vitrectomy for epiretinal membrane associated with sarcoidosis.
    Kiryu J; Kita M; Tanabe T; Yamashiro K; Ieki Y; Miura S; Miyahara S; Tamura H; Honda Y
    Jpn J Ophthalmol; 2003; 47(5):479-83. PubMed ID: 12967864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized, double-masked controlled clinical trial of Sandostatin long-acting release depot in patients with postsurgical cystoid macular edema.
    Shah SM; Nguyen QD; Mir HS; Polito A; Hafiz G; Tatlipinar S; Do DV; Vitale S; Haller JA
    Retina; 2010 Jan; 30(1):160-6. PubMed ID: 20061906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macular ischaemia in posterior uveitis.
    Bentley CR; Stanford MR; Shilling JS; Sanders MD; Graham EM
    Eye (Lond); 1993; 7 ( Pt 3)():411-4. PubMed ID: 8224296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapy of cystoid diffuse macular edema after uveitis and cataract surgery with the carbonic anhydrase inhibitor acetazolamide (Diamox)].
    Schilling H; Pauleikhoff D; Schrenk M; Wessing A
    Klin Monbl Augenheilkd; 1993 Mar; 202(3):206-11. PubMed ID: 8510414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.